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Follistatin-like Protein 1 (FSTL1) is a glycoprotein secreted by cardiac and skeletal muscle
tissues under stress conditions. An elevated level of plasma FSTL1 has been observed after a
single bout of exercise suggesting its potential myokine-like role involved in the crosstalk
between muscle and other organs. PURPOSE: To investigate autocrine effects of FSTL1 on
myotube differentiation, myosin heavy chain expression and mitochondrial respiration in
primary canine myoblasts. METHODS: All animal procedures were performed in accordance
with specific protocols approved by the Institutional Animal Care and Use Committee. Primary
myoblasts were isolated from canine gastrocnemius muscle. Myotube differentiation was
induced by a low serum condition for 4 days. Immunostainings were performed using MF20
antibody (rod-like tail region of myosin) and DAPI (nuclei); and fusion index was determined by
calculating the ratio between total number of nuclei and number of nuclei within myotubes
formed. RT-PCR assays were performed using primer sets precisely designed to specifically
amplify each fiber type-associated myosin heavy chain isoforms (i.e. MyHC 7, 2, 1, and 4).
Oxygen consumption of intact cells was measured using a Clark-type oxygen sensor; and
mitochondrial respiration was measured using Seahorse XF96 analyzer. RESULTS: During
myotube formation, FSTL1 treatment (300 ng/ml, 4 days) significantly enhanced myogenic
potential determined by fusion index (~2-fold increase). There was a significant increase in
MyHC 7 expression (~1.5 fold) in myotubes treated with FSTL1 during differentiation compared
to non-treated myotubes, whereas no significant differences were observed in other MyHC
isoforms. Chronic FSTL1 treatments (250 ng/ml, 64 hours) significantly increased oxygen
consumption in both intact myoblasts and myotubes. Acute FSTL1 treatment (up to 500 ng/ml,
either a single injection or 1-hour pre-incubation) had no significant effect on mitochondrial
respiration. CONCLUSION: Our preliminary data suggest that FSTL1 enhances differentiation
potential and increases oxidative metabolism in myogenic cells suggesting that FSTL1 may be
an important cellular mediator for the benefits of exercise in the context of skeletal muscle
adaptation.
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